Form 4: Anna U. Loengard Reports Changes in Beneficial Ownership of Clover Health Investments Corp. Shares

Anna U. Loengard, a director at Clover Health Investments Corp., reported the acquisition of Class A Common Stock through various accounts, including spousal and children's IRAs and custodial accounts.

Summary

• On May 16 and 17, 2024, Anna U. Loengard, a director of Clover Health Investments Corp., reported changes in her beneficial ownership of Class A Common Stock.
• She acquired 15,600 shares on May 16, 2024, at a price of $0.96 per share, and 1,485 shares at $0.94 per share through accounts held by her son and daughter.
• On May 17, 2024, she acquired 10,000 shares at $0.93 per share through her spouse's IRA.
• Following these transactions, Loengard directly owns 538,841 shares of Class A Common Stock.
• She also indirectly owns 10,000 shares through her spouse's IRA, 1,300 shares through her son's custodial account, 15,600 shares through her son's IRA, 1,500 shares through her daughter's custodial account, and 15,110 shares through her daughter's IRA.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The director's purchase of shares indicates confidence, but it's a routine transaction.

Positives

• Director Anna U. Loengard increased her investment in Clover Health Investments Corp., signaling confidence in the company.
• The purchases were made at prices ranging from $0.93 to $0.96, indicating a willingness to invest at current market valuations.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common in the healthcare and investment industries. Investors often monitor these filings for signals about management's confidence in the company's prospects.

Stakeholder Impact

• The increased holdings by a director could positively influence shareholder confidence.
• The transactions themselves have a minimal direct impact on employees, customers, suppliers, or creditors.

Key Dates